H.L. Ormond & Company’s Illumina ILMN Stock Holding History

H.L. Ormond & Company’s Portfolio ILMN Stock Details ILMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-696	Closed	-$237K	–	93
2022 Q1	$237K	Sell	696 -6	-0.9%	-$2.03K	0.29%	92
2021 Q4	$242K	Buy	+702	New	+$266K	0.28%	95

Other funds holding ILMN

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

H.L. Ormond & Company's ILMN Position: Q2 2022 in Review

H.L. Ormond & Company sold out of Illumina (ILMN) in Q2 2022, closing a stake of 696 shares — an estimated $237K sold.

H.L. Ormond & Company first reported a position in ILMN in Q4 2021 and held it in 2 quarters. The position peaked at $242K in Q4 2021. 911 funds tracked by Wall St. Rank hold ILMN as of Q2 2022.

H.L. Ormond & Company reported no remaining Illumina position as of Q2 2022 after selling out during the quarter.
H.L. Ormond & Company sold 696 Illumina shares in Q2 2022, an estimated $237K.
H.L. Ormond & Company first reported a position in Illumina in Q4 2021 and held it in 2 quarters.
H.L. Ormond & Company's Illumina position peaked at $242K in Q4 2021.
911 funds tracked by Wall St. Rank held Illumina as of Q2 2022.

Based on H.L. Ormond & Company's 13F filing for Q2 2022, filed 12 Aug 2022.